SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.410-6.6%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote ()10/18/1996 12:41:00 PM
From: Don W Stone   of 82
 
To Everyone,
On the Dow News today I am told: NVX announces that they are acquiring a manufacturing facility that was originally designed for vaccine production and is located across the street from the NVX DTaP plant. The new facility will be used to produce the Group B Strep, Group A Strep and four different meningitis vaccines.

That in itself is significant in that it does say to the world that NVX is alot more than a single product(DTaP) vaccine company.

This company is on a roll and I think we are going to be hearing alot more from them over the coming months IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext